TMTamara Malinka

Tamara Malinka

*This is an algorithmically generated author record based on publicly available information.

Tamara Malinka has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Drug resistance index calculation algorithm: methodology and practical application

    by T. Malinka, N. Kheifets, I. Kozhanova, Т. В. Малинка, Н. Е. Хейфец, И. Н. Кожанова

    Objective . To adapt the drug resistance index calculation methodology to electronic databases and drug consumption analysis tools available in the Republic of Belarus and to develop instructions detailing the sequence of steps required for the correct application of the methodology. Materials and methods . This study is methodological. It is based on a methodology for calculating the integrated drug resistance index. WHONET software, used to generate samples of microorganisms and their susceptibility to antimicrobials, is considered as the source of initial data. A demonstration example using simulated data is used to illustrate the method. Results . A step-by-step process for calculating the drug resistance index is presented, including formalization of all stages of data processing and indicator aggregation. The demonstration example illustrates the calculation sequence and the specifics of interpreting the final index value. Conclusion . Proposed approach ensures transparency and reproducibility in calculating the integrated drug resistance index and can be used to standardize data analysis. Detailed methodology facilitates its implementation in scientific and practical activities, objectifying it as a tool for making management decisions in the field of antibacterial therapy management.

  • Open Access

    Классификация AWaRe – готовый инструмент для работы или подспорье для разработки локальных актов

    by Т.в. Малинка, И.н. Кожанова, Н.е. Хейфец

    Improving the quality of management of antimicrobial therapy as a medical technology in healthcare settings is one of the main goals of the World Health Organization's global plan to combat antimicrobial resistance. As part of this activity, it is relevant to search for and implement into practice effective methods for analyzing the consumption of this group of drugs.The purpose of this study is to determine the place of the AWaRe classification in the development of local antimicrobial therapy management programs.Methods. ABC/VEN analysis and DDD (ATC/DDD methodology) were used to analyze the consumption of antimicrobial drugs. The consumption of antibacterial drugs was analyzed using the AWaRe method, 2023, based on the DDD and the WHO list of main antibiotics by groups: “Access” (A), “Watch” (W), “Reserve” (R), “Not recommended” (N). Statistical processing of the results was carried out using descriptive statistics methods using the MS Office EXCEL 2016 program.Results. An analysis of antibiotic consumption in four multidisciplinary hospitals in Minsk for 2022 and 2023 was carried out using pharmacoepidemiological DDD methodology and AWaRe classification. The study determined the place of this tool in the development ofantibacterial therapy management programs.Conclusions. The study noted that the use of the AWaRe classification as part of the development of an antibacterial therapy management program can complement the niche of descriptive data analytics, that is, it will make it possible to describe the structure of consumption of antibacterial drugs using a formalized, stereotypical international tool. This tool further provides an opportunity to implement diagnostic tasksto develop measures to influence the policy and practice of using antibacterial drugs.